Literature DB >> 26557076

Retroperitoneal Schwannoma in the Renal Hilum: A Case Report.

Yohei Kumano1, Takashi Kawahara2, Sawako Chiba3, Yoko Maeda1, Mari Ohtaka1, Takuya Kondo1, Taku Mochizuki1, Yusuke Hattori1, Jun-Ichi Teranishi1, Yasuhide Miyoshi1, Yasushi Yumura1, Yoshiaki Inayama3, Masahiro Yao4, Hiroji Uemura1.   

Abstract

A 73-year-old male was referred to our department for further treatment of a right retroperitoneal tumor. Contrast CT showed a tumor mass measuring 33 × 26 mm in size with poor contrast enhancement. Because we were unable to rule out tumor malignancy, we planned an operation. The tumor was easily separated and removed without nephrectomy. Histological study revealed a schwannoma. It is rare for this kind of tumor to arise from the retroperitoneum (approximately 0.7% of all cases), in particular at the renal hilum. We herein report a rare case of retroperitoneal schwannoma arising from the renal hilum.

Entities:  

Keywords:  Renal hilum; Retroperitoneal tumor; Schwannoma

Year:  2015        PMID: 26557076      PMCID: PMC4637795          DOI: 10.1159/000440612

Source DB:  PubMed          Journal:  Case Rep Oncol        ISSN: 1662-6575


Introduction

Schwannomas are derived from Schwann cells on the peripheral nervous system and appear most commonly in the head, neck and limbs [1]. Previous reports of schwannomas arising from the retroperitoneum have been reported; however, they are extremely rare [2]. We herein report a rare case of retroperitoneal schwannoma arising from the renal hilum.

Case Presentation

A 73-year-old male was referred to our department for further examination of a right retroperitoneal tumor in the renal hilum. There were no physical findings in particular. On abdominal CT and MRI, there was a tumor in the right hilum of the kidney, and it was well defined. Laboratory examination showed that only noradrenaline was slightly elevated at 809 ng/dl. Therefore, we continued to follow the patient. Due to the gradually increasing size of the tumor, we could not rule out malignancy. Thus, we planned tumor resection with nephrectomy. Because there was no adhesion or invasion around the tissue, we performed complete resection. The histological diagnosis was schwannoma. The tumor has not recurred for 5 months after resection.

Laboratory Data at the Time of Admission

Hematological biochemistry data showed almost no abnormal findings. The hormonal values were as follows: noradrenaline 809 ng/dl, adrenaline 46.0 pg/dl, dopamine 29 pg/dl, cortisol 13.2 μg/dl, ACTH 52.7 pg/dl, aldosterone 78.5 pg/dl, 11-hydroxycorticosteroids 18.1 pg/dl, and vanillylmandelic acid 9.5 ng/ml. On urinalysis, pH was 7.5, RBC 0–1/high power filed, WBC 0–1/high power field, protein (–), and glucose (–).

Imaging Finings

CT and MRI showed a mass measuring 4.5 × 4.0 cm in size in the renal hilum (fig. 1). Contrast CT showed that the tumor was poorly enhanced, whereas MRI showed that the inside was uniform on the T1-weighted image; however, there was heterogeneous contrast on the T2-weighted image. No obvious distant and local lymphoid metastasis was detected by bone scintigraphy, MRI, or CT.
Fig. 1

a Contrast-enhanced CT. b T2-weighted MRI.

Operative Procedure

We planned radical nephrectomy with complete tumor resection. As the tumor was surrounded by two renal arteries, a reverse L-shaped incision was made and the transperitoneal approach was performed. When we approached the target tumor, the tumor was capsuled, and the margin between the renal hilum and the tumor was easily recognized. Though the tumor was fed by some of the small vessels, the tumor was successfully resected without nephrectomy (fig. 2).
Fig. 2

Intraoperative image (a) and schematic illustration (b). IVC = Inferior vena cava.

Pathological Findings

The resected tumor measured 3.5 × 2.5 × 1.5 cm in size and was encapsulated. On cut section, the tumor had a yellow-tinted pink appearance with secondary degenerative changes, such as cystification and hemorrhage (fig. 3a). Microscopically, it was composed of spindle or oval cells with two distinct histological patterns: areas of compact, elongated cells with occasional nuclear palisading (Antoni A) and less cellular, loosely textured tumor areas (Antoni B; fig. 3b, c). According to these histological findings, the tumor was diagnosed as a schwannoma in the renal hilum.
Fig. 3

a Surgical specimen. The cut surface of the tumor shows cystic change and hemorrhage. b, c The histological features of the tumor show a biphasic pattern with cellular Antoni A (b) and hypocellular Antoni B (c) areas.

Discussion

Schwannomas arise frequently in the head and neck (44.9%) and the limbs (32.6%). It is rare for a schwannoma to arise at the retroperitoneum (approximately 0.7–3%) [3, 4, 5, 6, 7], and reports of schwannomas arising at the hilum are rare [2]. The behavior of a schwannoma appears to be silent, asymptomatic, and slow-growing, regardless of whether it is benign or malignant. The basic treatment for a schwannoma is tumor removal by operation because the effect of chemotherapy and radiation is poor. The prognosis is good; however, recurrence is possible, and therefore, postoperative follow-up is necessary. In this case, we suspected that the tumor was benign; however, on preoperative examination, we could not completely rule out malignancy. Due to the development and widespread use of laparoscopy, some cases have reported the successful removal of a retroperitoneal schwannoma using laparoscopic procedures [8]. In the present case, the tumor was pressing on the inferior vena cava and right renal arteries and veins. Furthermore, it was surrounded by two renal arteries. Thus, we initially planned transperitoneal surgery with nephrectomy. Hung et al. [1] reported that radical nephrectomy is recommended due to the difficulty of determining the preoperative diagnosis and the possibility of a malignant schwannoma. When we approached the tumor, it was encapsulated and did not show adhesion or invasion to the surrounding tissue; therefore, we removed the tumor without nephrectomy. We herein report a rare case of retroperitoneal schwannoma arising from the renal hilum.

Statement of Ethics

The authors have no ethical conflicts to disclose.

Disclosure Statement

The authors declare no conflicts of interest.
  8 in total

Review 1.  [Laparoscopic resection of retroperitoneal schwannoma : report of three cases and review of 22 cases in Japanese literature].

Authors:  Tetsuya Imao; Masaya Seki; Toshiyasu Amano; Katsuro Takemae
Journal:  Hinyokika Kiyo       Date:  2011-09

2.  Neurilemmoma of kidney--a rare occurrence.

Authors:  K F Ma; C H Tse; M S Tsui
Journal:  Histopathology       Date:  1990-10       Impact factor: 5.087

3.  Intrarenal schwannoma: a report of four cases including three cellular variants.

Authors:  I Alvarado-Cabrero; A L Folpe; J R Srigley; P Gaudin; A T Philip; V E Reuter; M B Amin
Journal:  Mod Pathol       Date:  2000-08       Impact factor: 7.842

4.  Benign solitary Schwannomas (neurilemomas).

Authors:  T K Das Gupta; R D Brasfield; E W Strong; S I Hajdu
Journal:  Cancer       Date:  1969-08       Impact factor: 6.860

5.  Renal Schwannoma: case report and literature review.

Authors:  Shun-Fa Hung; Shiu-Dong Chung; Ming-Kuen Lai; Shih-Chieh Chueh; Hong-Jeng Yu
Journal:  Urology       Date:  2008-03-07       Impact factor: 2.649

Review 6.  Neurilemoma of the kidney.

Authors:  A J Singer; K H Anders
Journal:  Urology       Date:  1996-04       Impact factor: 2.649

7.  Schwannoma of the kidney.

Authors:  Stefano Gobbo; John N Eble; Jiaoti Huang; David J Grignon; Mingsheng Wang; Guido Martignoni; Matteo Brunelli; Liang Cheng
Journal:  Mod Pathol       Date:  2008-04-04       Impact factor: 7.842

8.  [A case of schwannoma in the renal hilum].

Authors:  Makoto Iwasaki; Masazumi Nagashima; Yoji Nagashima; Koichi Udagawa
Journal:  Hinyokika Kiyo       Date:  2013-07
  8 in total
  1 in total

Review 1.  Giant renal schwannoma with obvious hemorrhage and cystic degeneration: a case report and literature review.

Authors:  Chao Feng Yang; Hui Zuo; Jin Hong Yu; Sushant Kumar Das; Yang Li
Journal:  BMC Urol       Date:  2022-07-11       Impact factor: 2.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.